Linking the Latest Research to Clinical Care in MS: Robert Bermel, MD


The director of the Mellen Center for MS at Cleveland Clinic offered an overview of the State of the Science Summit that was held on November 10, 2022, featuring a panel of expert clinicians. [WATCH TIME: 4 minutes]

WATCH TIME: 4 minutes

NeurologyLive® State of the Science events are short meetings designed to educate neurologists and APPs on the clinical benefits associated with the new science driving new thinking. Our renowned faculty focuses on the most relevant topics to ultimately improve patient care.

In this recent event, held on November 10, 2022, a panel of experts in the care of multiple sclerosis (MS) convened to discuss the recent data updates from the literature on the disease, focusing on PIRA as a contributor to disability, stem cell transplantation, neuromyelitis optica spectrum disorder, and how the field has managed through the COVID-19 pandemic.

Presentation topics include the following:

  • PIRA is the Major Contributor to MS Disability — Robert Bermel, MD
  • Autologous Hematopoietic Stem Cell Transplantation — Jeffrey Cohen, MD
  • Update on NMO and MOGAD — Amy Kunchok, MBBS, MMed
  • Management of MS through COVID-19 — Brandon Moss, MD

Click the button below to watch the recent State of the Science Summit with Bermel et al.

Institutional Perspectives in Neurology, Chaired by Robert T. Naismith, MD

For more information about other events, check out our Institutional Perspectives in Neurology: Multiple Sclerosis page.

Related Videos
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
Michael Kaplitt, MD, PhD
video 4 - "Amyloid Cascade Hypothesis of Alzheimer’s Disease"
Video 3 - "Amyloid Precursor Protein and Amyloid Beta Species in Alzheimer’s Disease"
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
© 2024 MJH Life Sciences

All rights reserved.